• Method development for simultaneous analysis of Amyloid β (Aβ) proteins

Bioanalytical

Method development for simultaneous analysis of Amyloid β (Aβ) proteins

Amyloid β (Aβ) are peptides of 36–43 amino acids that are the main components of amyloid plaques. The analysis of Aβ is not trivial as the Aβ peptides such as Aβ (1–42) are highly hydrophobic which leads to the formation of aggregates.

YMC has developed a method for the simultaneous determination of four Aβ using YMC-Triart Bio C4. As the hydrophobic Aβ have a tendency to form aggregates a stationary phase with lower hydrophobicity and a larger pore is needed. Therefore, YMC-Triart Bio C4 is the optimum column for this demanding separation. Due to the high chemical stability of YMC-Triart Bio C4 it is possible to do rapid method optimisation for complex mixtures of peptides and proteins utilising the wide pH and temperature range available. YMC-Triart Bio C4 is available with 3 and 5 μm for HPLC, as well as with fully scalable 1.9 μm for UHPLC.


Events

NGVS 2025

Mar 18 2025 Beijing, China

Forum Labo Paris

Mar 25 2025 Paris, France

CISILE 2025

Mar 31 2025 Beijing, China

Analytica Vietnam

Apr 02 2025 Saigon, Vietnam

Korea Lab 2025

Apr 22 2025 Kintex, South Korea

View all events

Redirecting you now.
Labmate Awards Nominations - Open
The Labmate Awards for Excellence 2025 seek to recognise innovation, quality and achievement wherever it occurs within the laboratory sector. Launching this year the Labmate Awards for Excellence 2025 will have eleven voting categories chosen to reflect the broad range of noteworthy contributions that have been made across our industry in the past 12 months. Nominate your company Now.